Pregnant rats,Cesarean section, Oxytocin, High performance liquid chromatography-mass
spectrometry, Pharmacokinetics
,"/> <span style="font-size:14px;line-height:2;">缩宫素在妊娠晚期及剖宫产术后大鼠</span><span style="font-size:14px;line-height:2;">体内的药代动力学研究</span>
Please wait a minute...
欢迎访问发育医学电子杂志,今天是
发育医学电子杂志  2022, Vol. 10 Issue (1): 31-37,69    DOI: 10.3969/j.issn.2095-5340.2022.01.006
  围产医学   论著 |产科 |
缩宫素在妊娠晚期及剖宫产术后大鼠体内的药代动力学研究
刘婷婷 曲冬颖
北部战区总医院和平分院 妇产科,辽宁 沈阳 110001
Study on pharmacokinetics of oxytocin in the late pregnancy and cesarean section ra
Liu Tingting, Qu Dongying
(Department of Obstetrics and Gynecology, Heping Branch, Northern Theater General Hospital, Liaoning, Shenyang 110001, China)
下载:  PDF (1065KB) 
输出:  BibTeX | EndNote (RIS)      
摘要 【摘要】 目的 探讨缩宫素在妊娠晚期及剖宫产术后大鼠体内药代动力学变化的特点,为缩宫素的临床应用提供参考。 方法 SPF 级SD 大鼠36 只随机分成6 组,每组6 只。A、B、C 组为妊娠晚期组,分别单次尾静脉注射0.1、0.5、5 U/kg 的缩宫素;D、E、F 组为剖宫产术后组,行剖宫产术后分别单次尾静脉注射0.1、0.5、5 U/kg 的缩宫素。6 组大鼠分别于给药后1、2、4、6、8、10、15、20、45、60 min 采血。采用高效液相色谱- 二级质谱联用(high performance liquid chromatography-mass spectrometry,HPLC-MS/MS)的方法测定缩宫素的血药浓度结果,计算缩宫素在大鼠体内的消除半衰期(T1/2)、药时曲线面积(areaunder the drug concentration time curve,AUC)、平均驻留时间(mean residence time,MRT)、表观分布容积(apparent volume of distribution,Vd)和血浆清除率(plasma clearance,CL)等药代动力学参数。统计学方法采用方差分析。 结果 ①在0.01 ~ 300 U/L 范围,缩宫素血药浓度与峰面积具有良好的线性关系,回归方程为y = 1143.36 x + 8.78(R2=0.9983)。血浆样品提取回收率较高。②妊娠晚期的A、B、C 组给予缩宫素后,血药浓度迅速升高,各时间点3 组间比较差异有统计学意义(P<0.05);与A 组相比,B 组和C 组T1/2 明显缩短(P<0.05);与A、B 组相比,C 组MRT 亦明显缩短(P<0.05);与A 组相比,C 组CL显著增加(P<0.05);3 组AUC 比较差异有统计学意义(P<0.05),随着给药浓度的增高,AUC 呈现递增趋势。③剖宫产术后的D、E、F 组给予缩宫素后,最大浓度时间(maximum concentration,Tmax)均为给药后1 min ;3 组间最大浓度(maximum concentration,Cmax)比较差异有统计学意义(P<0.05);与D 组相比,E 组和F 组T1/2 明显缩短(P<0.05);与D、E 组相比,F 组的MRT 亦明显缩短(P<0.05);与D 组相比,F 组CL 显著增加(P<0.05);3 组AUC 比较差异有统计学意义(P<0.05),随着给药浓度的增加,AUC呈现递增趋势。 结论 缩宫素在妊娠晚期及剖宫产术后大鼠体内的半衰期为7 ~ 10 min,达峰时间为1 min,缩宫素的最佳给药方式是持续静脉滴注给药;同时,随着给药浓度的增加,缩宫素在大鼠体内代谢加快,T1/2、MRT 变短,Vd、CL 和AUC 增加。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词:  孕鼠  剖宫产  缩宫素  高效液相色谱- 二级质谱联用  药代动力学    
Abstract: 【Abstract】 Objective To explore the effects of oxytocin in pharmacokinetic changes in the late pregnancy and cesarean section rats, for the clinical application of oxytocin. Methods 36 SPF grade SD rats were randomly divided into 6 groups, 6 rats in each group. A, B, C three groups were late pregnancy rats intravenously given 0.1, 0.5, 5 U/kg of oxytocin. D, E, F groups were cesarean section rats given by tail channels 0.1, 0.5, 5 U/kg of oxytocin. All the rats were collected blood at 1, 2, 4, 6, 8, 10, 15, 20, 45, 60 min after injection. We use the high performance liquid chromatography-mass spectrometry (HPLC-MS/MS) to detect the plasma concentration of oxytocin. The pharmacokinetic parameters such as half-life (T1/2), area under the drug concentration time curve (AUC), mean residence time (MRT), apparent volume of distribution (Vd) andplasma clearance (CL) of oxytocin were calculated according to the plasma concentration which has been measured. Statistical analysis were used with analysis of variance. Results ① In the range of 0.01-300 U/L, oxytocin plusmconcentration and peak area had good linear relationship, and the regression equation was y= 1143.36x + 8.78(R2 = 0.9983). The plasma samples extraction recovery rate was high. ② In the late pregnancy group, theplasma concentration increased after injection. There were significantly differences among group A, B andC (P<0.05) . Compared with group A , T1/2 of group B and C were shorter (P<0.05). Compared with groupA and B, the MRT of group C was also significantly shorter (P<0.05). Compared with group A, the CL of
group C increased significantly (P<0.05). AUC of three groups had significantly differences (P<0.05). With
the increase of drug concentration, AUC showed an increasing trend. ③ After injection of oxytocin, the Tmaxof group D, E and F were 1 min after injection. The maximum concentration (Cmax) of the three groups hadsignificant differences (P<0.05). Compared with the group D, T1/2 of group E and F were significantly shorter(P<0.05). Compared with group D and E, MRT of group F was also significantly shorter (P<0.05). Comparedwith group D, the CL of group F increased significantly (P<0.05). AUC of the three groups had significantlydifferences (P<0.05). As the concentration increased, AUC showed an increasing trend. Conclusions Thehalf-life of oxytocin is about 7-10 min in the late pregnancy and cesarean section rats, and the peak time is 1min. The best way of administration of oxytocin is continuous intravenous drip. At the same time, with the increase of oxytocin concentration, the metabolism of oxytocin accelerates. T1/2 and MRT shorten, while Vd, CL and AUC increase.
Key words:  Pregnant rats')" href="#">Pregnant rats    Cesarean section    Oxytocin    spectrometry')" href="#"> High performance liquid chromatography-mass
spectrometry
   ')" href="#"> Pharmacokinetics
收稿日期:  2020-04-09                     发布日期:  2022-01-28     
基金资助: 辽宁省科学技术计划项目(2021JH2/10300095)
通讯作者:  曲冬颖    E-mail:  38080806@qq.com
引用本文:    
刘婷婷 曲冬颖. 缩宫素在妊娠晚期及剖宫产术后大鼠体内的药代动力学研究[J]. 发育医学电子杂志, 2022, 10(1): 31-37,69.
Liu Tingting, Qu Dongying. Study on pharmacokinetics of oxytocin in the late pregnancy and cesarean section ra. Journal of Developmental Medicine(Electronic Version), 2022, 10(1): 31-37,69.
链接本文:  
http://www.fyyxzz.com/CN/10.3969/j.issn.2095-5340.2022.01.006  或          http://www.fyyxzz.com/CN/Y2022/V10/I1/31
[1] 金珈汐 孙静莉. 全面二孩政策实施前后的产妇特征及剖宫产指征分析[J]. 发育医学电子杂志, 2021, 9(5): 353-358.
[2] 陈佳 曲冬颖 曹岱 姜艳. 不同分娩方式的新生儿脐动脉血气分析比较[J]. 发育医学电子杂志, 2021, 9(4): 292-295.
[3] 邓丽君 张翠娟 徐学艳. 宫颈上提缝合术治疗前置胎盘剖宫产术宫颈管出血的效果[J]. 发育医学电子杂志, 2020, 8(2): 178-182.
[4] 刘娜 王硕. 妊娠合并巨大子宫肌瘤的临床特点及围产结局[J]. 发育医学电子杂志, 2020, 8(1): 42-46.
[5] 孙瑞清 郑剑兰 刘景兮 张小琼 汪文雁 陈琼. 双球囊导管在瘢痕子宫足月妊娠中的应用[J]. 发育医学电子杂志, 2019, 7(3): 208-213.
[6] 杨雪梅 尚丽新. 足月胎膜早破破膜时间长短对围产结局的影响[J]. 发育医学电子杂志, 2018, 6(2): 82-85.
[7] 孙燕 付玉静 翟建军. 妊娠晚期子宫破裂14例分析[J]. 发育医学电子杂志, 2017, 5(4): 248-252.
[8] 李文. 剖宫产术后子宫瘢痕缺损的再生育问题[J]. 发育医学电子杂志, 2016, 4(3): 140-144.
[1] Society of Neonatologist, Chinese Medical Doctor Association. Consensus recommendations on the prevention and early management of respiratory distress syndrome in preterm infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 129 -131 .
[2] Professional Committee of Respiratory, Society of Neonatologist, Chinese Medical Doctor Association. Clinical application recommendations for heated humidified high flow nasal cannula[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 132 -135 .
[3] YAN Jun, ZHU Xing-wang, SHI Yuan. Application progress of noninvasive ventilate technique for premature infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 136 -140 .
[4] GU Min-fang, YANG Chuan-zhong. Progress of intrapartum resuscitation for premature infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 141 -145 .
[5] LIU Shu-hua, SHEN Yue-bo, LIU Cui-qing, MA Li. The efficacy of pulmonary surfactant for pulmonary function in premature tension pneumothorax[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 146 -151 .
[6] GAO Xiao-hui, MAO Jian. Clinical features of non-oliguric hyperkalemia in extremely low birth weight infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 152 -158 .
[7] XIA Yao-fang, YANG Juan , TIAN Bao-li, et al. Value of amplitude-integrated electroencephalography in monitoring acute period of neonatal bilirubin encephalopathy and prognostic assessment[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 159 -163 .
[8] WANG Li-rong, SUN Xiao-yan, ZHU Ruo-xin, et al. Epidemiological investigation and analysis of women aged 40-55 years old with osteoporosis in Gansu province[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 164 -167 .
[9] CHEN Ru-yue, SHEN Yun-yan, CHEN Qing , et al. Five cases about Henoch-Schönlein purpura complicated with central nervous system injury in children and literatures review[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 168 -171 .
[10] ZHANG Ai-run, FANG Xiao-yi. Lung function testing of bronchopulmonary dysplasia for infants and children[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 172 -176 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed